Publication | Open Access

Phase I trial of intravenous aviscumine (rViscumin) in patients with solid tumors: a study of the European Organization for Research and Treatment of Cancer New Drug Development Group

Surgical OncologySolid TumorsMedicinePharmacologyPharmacotherapyAnti-cancer AgentEuropean OrganizationCancer TreatmentOncologyRadiation OncologyCancer ResearchIntravenous Aviscumine